Newman Brian 4

What Happened

• Brian Newman, a director of Colgate-Palmolive Co. (CL), received two annual compensation awards on May 11, 2026: 2,075 unrestricted shares (stock award) and a derivative award covering 2,424 shares (stock option grant). Both were reported at $0.00 per share (awards, not purchases), so no cash changed hands in the filing.

Key Details

• Transaction date: May 11, 2026; Form 4 filed May 13, 2026.
• Awarded amounts: 2,075 shares (stock award) and 2,424 derivative shares (option grant); reported price $0.00.
• Shares owned after the transaction: not specified in the provided filing details.
• Footnotes: F1 = annual director stock grant; F2 = annual director stock option grant; F3 = option vests in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.
• Filing timeliness: Form 4 was filed two days after the grant date (within the standard two-business-day reporting window), so not flagged as late.

Context

• These awards are routine director compensation and are not purchases or sales; they do not by themselves indicate a buy/sell market signal. The 2,424-share derivative is an option-like grant that vests over three years (not immediately exercisable).